Welcome to our dedicated page for Predictive Oncology SEC filings (Ticker: POAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Predictive Oncology Inc. (NASDAQ: POAI), which is changing its name to Axe Compute Inc. with an expected ticker change to AGPU, provides access to the company’s official regulatory disclosures. These documents include current reports on Form 8‑K, proxy statements, and other filings that describe material events, governance decisions, financing transactions, and listing matters.
Recent Form 8‑K filings detail several key developments. One 8‑K reports the adoption of a digital asset treasury strategy supported by private placements involving cash and in‑kind contributions of ATH, the native utility token of the Aethir ecosystem. Other 8‑Ks describe the launch and terms of these private placements, related registration rights agreements, and the use of proceeds to acquire ATH and support working capital and general corporate purposes. Additional 8‑Ks cover the 1‑for‑15 reverse stock split of the company’s common stock, actions taken to address Nasdaq listing requirements, and the company’s belief that it has regained compliance with Nasdaq’s minimum stockholders’ equity requirement.
The filings also document corporate governance and shareholder matters. A definitive proxy statement on Schedule DEF 14A outlines proposals for the annual meeting, including the election of directors, ratification of the independent auditor, amendments to the 2024 Equity Incentive Plan, approval of the issuance of shares upon exercise of pre‑funded warrants, and a non‑binding advisory vote on executive compensation. Another 8‑K describes shareholder approval of these items and the resulting increase in shares available under the equity plan.
One notable 8‑K filing reports the corporate name change from Predictive Oncology Inc. to Axe Compute Inc., effective December 11, 2025, and states that the Nasdaq ticker symbol is expected to change from POAI to AGPU on or about December 12, 2025. The filing notes that outstanding stock certificates remain valid and that the CUSIP number for the common stock will not change in connection with the name change.
Through Stock Titan, users can review these SEC filings in sequence and, with AI‑powered summaries, quickly understand the implications of complex documents such as 8‑Ks, proxy statements, and registration‑related supplements. This includes identifying how financing structures, equity plans, reverse splits, and digital asset strategies affect the company’s capital structure and governance over time.
Axe Compute Inc. reported that President Kyle Robert Okamoto received a grant of 300,000 non-qualified stock options on April 1, 2026 as a compensation award. The options have an exercise price of $1.62 per share and expire on March 31, 2036.
The grant was issued as an inducement award under Nasdaq Listing Rule 5635(c)(4). One third of the options vest on the first anniversary of the grant date, and the remaining two thirds vest in equal monthly installments over the following 24 months, contingent on Mr. Okamoto’s continued employment.
Axe Compute Inc. President Okamoto Kyle Robert reported his initial beneficial ownership of company stock. The filing shows 244,389 shares of common stock held indirectly through Okalina Ventures LLC.
Okamoto is the managing member of Okalina Ventures LLC and may be deemed to have an indirect pecuniary interest in these shares, while disclaiming beneficial ownership beyond that interest. The reported securities were issued upon conversion under a securities purchase agreement between Axe Compute Inc. and Okalina Ventures LLC dated September 29, 2025.
Axe Compute Inc. appointed Kyle Okamoto as President effective April 1, 2026, under an employment agreement providing a $360,000 base salary, a target annual bonus of $500,000, and stock options for 300,000 shares at a $1.62 exercise price, vesting over four years. The company also reported signing about $12 million in executed agreements over the last 30 days, expected to generate an estimated $835,000 in monthly income upon deployment entering Q2 2026, or roughly $7.5 million of estimated income from signed contracts in 2026 across more than 20 enterprise customers and 30 active deployments.
Axe Compute Inc. reported full-year 2025 results that reflect a major strategic pivot to AI GPU infrastructure and a digital asset treasury model, alongside a very large accounting loss. Revenue was modest at $125,284, all from the legacy Drug Discovery Services segment, with no compute revenue yet recognized.
The company recorded a loss from continuing operations of $232.9 million, driven mainly by $152.5 million in unrealized losses on ATH digital assets and a $52.7 million loss on derivative instruments, plus higher operating expenses as it repositioned the business. Despite this, Axe raised $343.5 million through October 2025 PIPE transactions and held $10.8 million in cash and $24.4 million of unlocked ATH tokens as of December 31, 2025.
These transactions transformed the balance sheet from a stockholders’ deficit to $47.7 million in equity and funded a Strategic Compute Reserve tied to the Aethir ATH token. The company established marketplace access to over 435,000 GPUs globally and plans to prioritize generating initial compute revenue, staking ATH for yield, and completing a review of strategic alternatives for its Helomics legacy business in 2026.
Axe Compute Inc. reported that CEO and Director Christopher Miglino received a grant of 500,000 non-qualified stock options. The options have an exercise price of $2.4400 per share and expire on February 8, 2036, giving him the right to buy an equal number of common shares at that price.
The award was granted as an inducement under Nasdaq Listing Rule 5635(c)(4) and is subject to a three-year vesting schedule. One-third vests on the first anniversary of the grant date, with the remaining two-thirds vesting in equal monthly installments over the following 24 months, contingent on his continued employment.
Axe Compute Inc. filed an initial insider ownership report for CEO and Director Christopher Miglino. The Form 3 shows that he holds 1,800 shares of Common Stock directly as of the reported date. This filing records his starting equity position and does not reflect any recent buy or sell transaction.
Axe Compute Inc. appointed Dr. Theodore Zhu and Mr. Thorston Dirks to its board of directors. Dr. Zhu is Founder and Chairman of Iotelligent Technology, with prior leadership roles at Celestial Semiconductor, Jazz Semiconductor, BitShield, Conexant, Honeywell, Motorola, and Brown University.
Mr. Dirks brings nineteen years of board-level experience and about fifteen years as Chief Executive Officer in telecommunications and aviation, including leading E-Plus Group, Telefónica Deutschland, and Deutsche Glasfaser, and serving on the executive boards of Deutsche Lufthansa AG, KPN N.V., and Telefónica S.A. Their director compensation will align with the company’s existing director compensation program.
Axe Compute Inc. is undergoing a major leadership transition. The board terminated Chief Executive Officer Raymond F. Vennare without cause, effective February 9, 2026, and he resigned as chairman and director. He will receive $575,000 in severance, a $287,500 2025 bonus, and a healthcare-related lump-sum payment under a separation agreement.
The company appointed director Chuck Nuzum as chairman and named Christopher Miglino as the new CEO and a director, effective the same date. Miglino brings more than 25 years of experience leading public and private technology and fintech businesses and has been involved in structuring Axe Compute’s digital asset treasury and AI compute strategy. His employment agreement provides a $575,000 annual base salary, bonus eligibility, and an inducement stock option grant for 500,000 shares that vest over three years. A related press release highlights the company’s focus on decentralized GPU compute, AI infrastructure, and a treasury-backed compute strategy.
Predictive Oncology Inc. is changing its corporate name to Axe Compute Inc., effective December 11, 2025. The change was approved by the board of directors under Delaware law and did not require a stockholder vote.
In connection with the name change, the company adopted Third Amended and Restated Bylaws that update the corporate name and integrate prior amendments, with no other substantive changes. The company’s common stock is expected to begin trading on Nasdaq under the new ticker symbol AGPU on or about December 12, 2025. Existing stock certificates remain valid and do not need to be exchanged.